Thank you for your interest in post-marketing study information. The Post-Marketing Study Registration System on this website has ceased updates as of January 1, 2025, and related information is no longer provided on this platform.

For inquiries about post-marketing studies or related research information, we recommend exploring other resources that provide clinical trial information, such as the Taiwan Clinical Trials (TaiwanClinicalTrials.tw), clinical trial centers at major hospitals, or the website of Center for Drug Evaluation (https://www1.cde.org.tw/ct_taiwan/introduction.html).

We appreciate your understanding and continued support!

Company Name	Title of Study	Update Date
Bayer	XAMINA / Xarelto® on prevention of stroke and non-central nervous system systeMIc embolism in treatment Naïve Asian patients with non-valvular atrial fibrillation.	2020-12-25
Astellas Pharma Taiwan, Inc.	A Phase IV Interventional Safety Study of ELIGARD® in Prostate Cancer Patients in Asia (ELIGANT)	2020-12-25
AbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan BranchAbbVie Biopharmaceuticals GmbH Taiwan Branch AbbVie	Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan	2020-12-25
Astellas Pharma Taiwan, Inc.	Non-interventional Study on the Safety and Efficacy of Micafungin for Prevention and Treatment of Fungal Infections in Pediatric Patients in Asia/Oceania – ERADICATE Study	2020-12-25
Daiichi Sankyo Taiwan	Non-interventional study on edoxaban treatment in routine clinical practice for patients with non valvular atrial fibrillation in Korea and Taiwan	2020-12-25
Daiichi Sankyo Taiwan	Non-Interventional Study on Edoxaban Treatment in Routine Clinical Practice in Patients with Venous Thromboembolism in Korea and Taiwan	2020-12-25
Pfizer Inc.	Health-related quality life and health utility among Taiwanese women with advanced/metastatic breast cancer	2020-12-25
Novartis (Taiwan) Co., Ltd	Registry of Ruxolitinib Treatment in Patients with Intermediate-2 or High Risk of Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), or Post-essential Thrombocythemia Myelofibrosis (PET-MF)	2020-12-25
Novartis (Taiwan) Co., Ltd	A non-interventional, prospective 12-months study to characterize the REAL-life effectiveness and treatment pattern of Secukinumab and current standard of care in patient with chronic plaque psoriasis eligible for systemic treatment in the Asia-Pacific and Middle East regions (REALIA)	2018-09-18
Bayer Taiwan Co., Ltd.	EXPERT, EXPosurE Registry RiociguaT in patients with pulmonary hypertension	2018-09-18